On the manufacturer side, Benefits and Pensions Monitor , citing Reuters and The Globe and Mail , reported that Eli Lilly planned to cut the Canadian list price of a four-week supply of Mounjaro and Zepbound to $300 for the 2.5 mg and 5 mg doses and $420 for the 7.5 mg and 10 mg doses, with the new prices taking effect December 29 [Source: benefitsandpensionsmonitor.com/benefits/pharma/eli-lilly-cuts-canadian-obesity-drug-prices/392905]
BPAs potential health risks: pregnancy, fertility, obesity, and diabetes, and the socioeconomic confounders in the data [1:08:30]
Vermillion: There is a very narrow strip of vermillion present in a bilateral cleft lip
It bears repeating clearly: peptides such as BPC-157 and TB-500 are not approved for human use by the FDA or EMA, their long-term safety in humans is not established, and much of the evidence base comes from animal or preclinical studies rather than large human trials
The type of L-carnitine that you choose matters, too